Pacific Biosciences Of California reported $-37573000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agilent A:US $ 351M 33M
Bruker BRKR:US $ 89.6M 3.5M
Danaher DHR:US $ 2005M 8M
Fluidigm FLDM:US $ -17268000 2.05M
General Electric GE:US $ 758M 100M
Genmark Diagnostics GNMK:US $ -2087000 821K
Illumina ILMN:US $ 187M 6M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -19000000 27.7M
Nanostring Technologies NSTG:US $ -25635000 233K
Oxford Immunotec Global OXFD:US 275K 10.11M
Pacific Biosciences Of California PACB:US $ -37573000 3.86M
Perkinelmer PKI:US $ 323.32M 164.31M
Quidel QDEL:US $ 24.33M 200.58M
Thermo Fisher Scientific TMO:US $ 2282M 805M
Waters WAT:US $ 195.85M 24.58M